# A Clinical Observation of 1064-nm Q-Switched Fractional Laser Combined With Oral Tranexamic Acid on Treating of Melasma.

> **NCT03963466** · NA · COMPLETED · sponsor: **xjpfW** · enrollment: 30 (actual)

## Conditions studied

- Melasma

## Interventions

- **DRUG:** tranexamic acid
- **RADIATION:** 1064-nm Q-Switched fractional laser
- **RADIATION:** 1064-nm Q-Switched laser

## Key facts

- **NCT ID:** NCT03963466
- **Lead sponsor:** xjpfW
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-05-01
- **Primary completion:** 2020-02-01
- **Final completion:** 2020-05-01
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2021-03-11

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03963466

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03963466, "A Clinical Observation of 1064-nm Q-Switched Fractional Laser Combined With Oral Tranexamic Acid on Treating of Melasma.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03963466. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*